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Transfection of human oral squamous carcinoma cells (clone E10) with mimics for
unexpressed miR-20b or miR-363-5p, encoded by the miR-106a-363 cluster (miR-20b,
miR-106a, miR-363-3p, or miR-363-5p), caused 40–50% decrease in proliferation.
Transfection with mimics for miR-18a or miR-92a, encoded by the miR-17-92 cluster
(all members being expressed in E10 cells), had no effect on proliferation. In contrast,
mimic for the sibling miRNA-19a yielded about 20% inhibition of proliferation. To
investigate miRNA involvement profiling of miRNA transcriptomes were carried out
using deoxyoligonucleotide microarrays. In transfectants for miR-19a, or miR-20b or
miR-363-5p most differentially expressed miRNAs exhibited decreased expression,
including some miRNAs encoded in paralogous miR-17-92—or miR-106b-25 cluster. Only
in cells transfected with miR-19a mimic significantly increased expression of miR-20b
observed—about 50-fold as judged by qRT-PCR. Further studies using qRT-PCR showed
that transfection of E10 cells with mimic for miRNAs encoded by miR-17-92 - or
miR-106a-363 - or the miR-106b-25 cluster confirmed selective effect on expression on
sibling miRNAs. We conclude that high levels of miRNAs encoded by the miR-106a-363
cluster may contribute to inhibition of proliferation by decreasing expression of several
sibling miRNAs encoded by miR-17-92 or by the miR-106b-25 cluster. The inhibition
of proliferation observed in miR-19a-mimic transfectants is likely caused by the
miR-19a-dependent increase in the levels of miR-20b and miR-106a. Bioinformatic analysis
of differentially expressed miRNAs frommiR-106a, miR-20b and miR-363-5p transfectants,
but not miR-92a transfectants, yielded significant associations to “Cellular Growth and
Proliferation” and “Cell Cycle.” Western blotting results showed that levels of affected
proteins to differ between transfectants, suggesting that different anti-proliferative
mechanisms may operate in these transfectants.
Keywords: miR-17-92, miR-106-363, miR-106b-25, miR-20b, miR-92a, miR-363-5p proliferation, cancer
INTRODUCTION
MicroRNAs (miRNAs) are associated with regulation of bio-
logical phenomena ranging from cancer (for review see Lee
and Dutta, 2009) to cardiac ischemic tolerance (Dharap and
Vemuganti, 2010). Some miRNAs are transcribed from a single
polycistronic transcript, e.g., the miR-17-92 cluster and its two
paralogs, the miR-106a-363 and miR-106b-25 clusters (Bartel,
2004; He et al., 2005; Zhang et al., 2009). Fifteen miRNAs
encoded by these three clusters can be separated into four families
based on their seed sequences (Figure 1). The miR-17-92 cluster,
located on human chromosome 13, encodes six miRNAs: miR-
17, miR-18a, miR-19a, miR-20a, miR-19b-1, and miR-92-1. The
miR-106a-363 cluster, located on human chromosome X, encodes
six miRNAs: miR-106a, miR-18b, miR-20b, miR-19b-2, miR-92-
2, and miR-363. The miR-106b-25 cluster, located on human
chromosome 7, encodes three miRNAs: miR-106b, miR-93, and
miR-25. While the miR-17-92 and miR-106a-363 clusters reside
in introns of non-coding genes, the gene encoding miR-106b-25
is located in intron 13 of MCM7 (Mendell, 2008).
High levels of expression of members of the miR-17-92 cluster
have been observed in tooth germs, in developing tissues and in
carcinoma cells (Lu et al., 2007; Jevnaker and Osmundsen, 2008;
Jevnaker et al., 2011). Knock-out of this cluster caused defec-
tive embryonic development and early post-natal death (Ventura
et al., 2008), while mice with knock-out for themiR-106b-25 clus-
ter and/or the miR-106a-363 cluster exhibited nomarked changes
in phenotype (Ventura et al., 2008). In mice the miR-106a-
363 cluster is normally not expressed except following retroviral
integration at the Kis2 locus (Landais et al., 2007).
Substantial inter-dependence between levels of microRNAs
and activity of signaling pathways is likely (Avraham and Yarden,
2012), as exemplified by miRNA-dependent regulation of cell
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FIGURE 1 | Schematic illustration of structures of the three paralogous
miR-17-92-, miR-106a-363-, and miR-106b-25 clusters. The structure of the
genes encoding three paralogous, polycistronic, miRNA clusters: the
miR-17-92 cluster, the miR-106a-363 cluster and the miR-106b-25 cluster. The
resulting mature miRNAs have been partitioned into four groups according to
degrees of homologies of their seed sequences. The light-blue colored
rectangles indicate positions of the mature miRNAs within the pre-miRNA
structures.
cycle and of apoptosis (Jovanovic and Hengartner, 2006; He et al.,
2011). Our preliminary studies had revealed that, among mem-
bers of the miR-106a-363 cluster, only miR-106a was detectable in
human cultured squamous carcinoma cells (clone E10), while all
sibling miRNAs from the paralogous cluster were expressed. This
observation elicited a study of effects of transfection with mim-
ics for unexpressed members of the miR-106a-363 cluster on E10
cells. Effects on proliferation and apoptosis were studied using
flow-cytometry, while effects on miRNA transcriptomes were
investigated using microarrays and qRT-PCR. The results sug-
gested that these miRNAs significantly diminished proliferation
of E10 cells. Also, in all transfectants investigated distinct popu-
lations of differentially expressed miRNAs were found, although
bioinformatic analysis revealed these populations to exhibit sig-
nificant associations with identical cellular functions (e.g., “Cell
Cycle,” “Cell Death” and “Cellular Growth and Proliferation”).
The more highly expressed siblings, miR-19a and 92a, were used
as “controls.”
Follow-up studies using qRT-PCR revealed that the “anti-
proliferative” miR-363-5p markedly decreased expression of all
other miRNAs in the three clusters. Although transfectants for
both miR-19a -and miR-20b-mimic exhibited diminished pro-
liferation expression of only a few sibling miRNAs were now




Human squamous carcinoma cell lines [clone E10 (PE/CA-PJ49)
and clone C12 (PE/CA-PJ34)], were obtained from the European
Collection of Cell Cultures (ECACC). Human colon cancer cell
lines (HTC116 and HT29) were purchased from the American
Type Culture Collection (ATCC). The cells were grown in Iscove’s
Modified Dulbecco’s Medium (Sigma-Aldrich, St. Louis, MO,
USA), supplemented with 10 % (v/v) FBS, 2mM L-glutamine,
1 % (v/v) penicillin, 1% (v/v) streptomycin and 0.25µg/ml
amphotericin B (all reagents purchased from Lonza, Basel,
Switzerland).
Primary human normal oral keratinocytes (KCs) were isolated
from biopsy samples after third molar extraction (13). The pro-
cedure had been approved by the Ethics Committee in Norway.
Primary KC and HaCaT cells (a gift from Dr. Eshrat Babaie,
The Biotechnology Centre, University of Oslo) were grown in KC
serum free medium (KSFM) supplemented with 1 ng/ml human
recombinant epidermal growth factor and 25mg/ml bovine pitu-
itary extract (GibcoBRL, Dorset, UK). The medium was fur-
ther added 1% (v/v) penicillin, 1% (v/v) streptomycin, and
0.25mg/ml amphotericin B (Lonzo, Basel, Switzerland). The cells
were split twice weekly at 80% confluence. Only freshly isolated
KC cells were used experimentally.
TRANSFECTION OF THE E10 CELLS WITH miRNA MIMICS OR WITH
SCRAMBLED CONTROL
Cells (E10) were incubated in IMDM medium with 5% FBS and
transfected using INTERFERin (Polyplus-Transfection, Illkirch,
France) according to the manufacturer’s protocol. Transfections
were carried out using 20 nM of miR-19a -, miR-20b -,
or miR-92a -, or miR-363-3-p -, or miR-363-5-p mimic or
Allstar scrambled control (Qiagen, Hilden, Germany), or with
transfection reagent only (MOCK). All miRNA mimics were
purchased fromGenePharma, Shanghai, China. Transfection effi-
ciencies were evaluated by flow-cytometry using the FACSCalibur
flow-cytometer (Becton Dickinson, Heidelberg, Germany) with
FITC-labeled scrambled RNA, and found>95% effective.
IMAGING AND COUNTING OF CELLS IN CULTURE
At 72 h post-transfection the cell cultures were photographed
using a Zeiss Axiovert 25 microscope at 5x magnification (Carl
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Zeiss, Jena, Germany). Following trypsination, cells were counted
using Beckman Coulter Z2 (Beckman Coulter, Inc., Fullerton,
CA, USA).
ASSAY FOR APOPTOSIS OR PROLIFERATION USING FLOW CYTOMETRY
Transfected cells were assayed for apoptosis and cell death by
flow-cytometry using the Single Channel Annexin V/Dead Cell
Apoptosis Kit with Alexa Fluor® 488 annexin V and SYTOX®
Green for Flow Cytometry (Invitrogen, Carlsbad, CA, USA).
At 72 h post-transfection cells were harvested by trypsination
according to the manufacturer’s protocol. About 500.000 cells
were incubated in 200µl annexin-binding buffer in the presence
of Alexa Fluor 488 annexin V (Component A) and 50 nM SYTOX
Green for 30min prior to analysis. Floating cells, which consti-
tuted<10% of the total number of cells, were also included in the
assay. E10 cells incubated with mitomycin C (10µg/ml) for 20 h
prior to analysis were used as positive control.
Cell proliferation was assayed using the Click-iT EdU Alexa
Fluor® 488 assay kit (Life Technologies Ltd, Paisley, UK) as rec-
ommended by the manufacturer. E10 cells were incubated with
15µM EdU for 2 h prior to fixation and labeling for analysis.
The assays were carried out using the FACSCalibur
flow-cytometer equipped with CellQuest software.
SELECTED mRNA TARGETS AND PROTEINS FOR QRT-PCR AND
WESTERN BLOTTING
UsingMicroCosm (http://www.ebi.ac.uk/enright-srv/microcosm/
cgi-bin/targets/v5/search.pl) KRT14 was found to be targeted
by miR-363-5p. Target search using Ingenuity Pathway Analysis
(IPA, http://www.ingenuity.com) suggested KRT15 to be targeted
by miR-363-5p. SVMicro (Liu et al., 2010) suggested ATF1,
KRT14, KRT15, PSMB6 as potential targets for miR-20b and
miR-363-5p. IPA and SVMicro also suggested EGFR as target for
miR-20b.
Preliminary mRNA profiling using microarrays (results not
shown) had suggested that ATF1, KRT14, KRT15, PSMB6 were
differentially expressed in miR-363-5p transfectants and AFT1
and PSMB6 in miR-20b transfectants. Levels of ATF1, KRT14,
KRT15, PSMB6, and EGFR were also assayed using qRT-PCR.
Levels of expression were normalized using the mRNA encod-
ing the TATA-binding protein (TBP) as house-keeping gene as
this gene was found to exhibit constant levels of expression. The
required primers were designed using Primer 3 software (Rozen
and Skaletsky, 2000). The primers used were: ATF1; ATF1-f:
TCTGGAGTTTCTGCTGCTGT, ATF1-r: ACTGTAAGGCTCCA
TTTGGG), EGFR; EGFR-f: GGAGAACTGCCAGAAACTGACC,
EGFR-r: GCCTGCAGCACACTGGTTG, KRT14; KRT14-f:
GGCCTGCTGAGATCAAAGAC, KRT14-r: TCTGCAGAAG
GACATTGGC, KRT15; KRT15-f: AGCCCAGAATGCGAC
TACAG, KRT15-r: GCATTGTCGATCTCCAGGAT, PSMB6;
PSMB-f: AACCACTGGGTCCTACATCG, PSMB6-r: CAGCT
ACTGCCTGGGTATCA, TBP; TBP-f: CGTGGCTCTCTTATC
CTCATGA, TBP-r: GCCCGAAACGCCGAATATA.
The High-Capacity cDNA Reverse Transcription Kit was used
to reversely transcribe mRNAs contained in 2µg of DNase-
treated total RNA using random primers (Applied Biosystems,
CA, USA). Each reverse transcription reaction (total volume of
20µl) was prepared according to the manufacturer’s protocol and
run in an Eppendorf MasterCycler (Eppendorf GmBh, Hamburg,
Germany). The Stratagene MX 3005 qRT-PCR instrument was
used together with the SYBR Green green-based qRT-PCR core
kit (Eurogentec, Seraing, Belgium). Every sample was assayed in
technical and biological triplicates.
ISOLATION OF RNA
Total RNA was extracted 72 h after transfection from E10 cells
transfected with miRNA mimics or scrambled control, and from
C12, HTC116, and HT29 cells, using the RNeasy Mini Kit as
described by the manufacturer (Qiagen, Hilden, Germany). The
RNA samples were treated with the TURBO DNA-free kit (Life
Technologies Ltd, Paisley, UK) to remove contaminating genomic
DNA.
RNA-fractions enriched with respect to miRNAs were iso-
lated according to the manufacturer’s protocol from trans-
fected E10 cells using the mirPremier microRNA isolation kit
(Sigma-Aldrich, St. Louis, MO, USA).
Concentrations of solutions of purified RNA were assayed
using the Nanodrop ND-1000 spectrophotometer. RNA fractions
exhibiting a ratio of OD260/OD280 andOD260/OD230 of at least
1.8 and 2.0, respectively, were used for further analysis.
MICROARRAY MAPPING OF miRNAs EXHIBITING SIGNIFICANTLY
CHANGES IN LEVEL OF EXPRESSION
MiRNAs with significantly altered expression following trans-
fection with mimics for miR-19a, miR-20b or miR-363-5p
on miRNA were identified using human deoxyoligonucleotide
microarrays for miRNA (OneArray®Microarray v2). The miRNA
arrays contain 100% of Sanger miRBase v15 miRNA content, i.e.,
1087 unique miRNA probes. All miRNA probes were printed in
triplicates. MiRNA-enriched fractions (about 500 ng of RNA),
isolated with mirPremier microRNA kit, were labeled with
Cy3 or Cy5 using Kreatech ULS labeling of miRNA (Kreatech,
Amsterdam, Netherlands).
Hybridization of labeled miRNA was carried out at 41◦C
for 18 h in a SlideBooster 400 Hybridization Station (Advalytix,
Munich, Germany). Microarray analysis was carried out in tech-
nical and biological triplicates. The microarrays were scanned in
a Packard Bioscience Scanarray Lite microarray scanner (Perkin-
Elmer, Waltham, MA, USA). The Cy3 and Cy5 fluorescence sig-
nals were quantified by using the ScanArrayExpress v.3.0 software
(Perkin-Elmer, Waltham, MA, USA). All microarray data have
been have been deposited in the ArrayExpress database with
reference E-MTAB-1395.
STATISTICAL ANALYSIS OF MICROARRAY DATA
Fluorescence-intensities were filtered using following criteria:
only miRNAs with consistent fluorescence-intensities for each set
of triplicate spots were used, and spots with net median fluores-
cence intensities of less than twice median background fluores-
cence intensity were excluded from further analysis. The statistical
analysis was carried out using SPOTFIRE v. 9.0 DecisionSite
for Microarray Analysis software (TIBCO Software, Palo Alto,
CA, USA).
Microarray data were subjected to single channel analy-
sis using log2 net fluorescence-intensities (median values, with
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FIGURE 2 | Effects of transfection with mimic for miR-19a, miR-20b,
miR-92a, miR-363-3p (miR-363), or miR-363-5p (miR-363∗) on cell
densities of cultured human squamous carcinoma (E10) cells. (A) Cells
from the carcinoma cell line E10 was transfected with different miRNA
mimics (miR-19a, miR-20b, miR-92a, miR-363-3p, or miR-363-5p). Typical
micrographs of cells subjected exposed to transfection medium only (Mock),
or transfected with scrambled control RNA, or with one of the miRNA-mimics
are shown in (A1). Typical results obtained using the Single Channel Annexin
V/Dead Cell Apoptosis Kit with cells transfected miR-363-5p-mimic showing
no evidence of induced apoptosis. E10 cells incubated with mitomycin C to
induce apoptosis served as positive controls for apoptosis (A2). Cells counts
following transfection with scrambled control or with mimic for miR-20b,
miR-92a, miR-363-3p, or miR-363-5p (means derived from three separate
(Continued)
Frontiers in Genetics | Non-Coding RNA August 2014 | Volume 5 | Article 246 | 4
Khuu et al. Polycistronic miRNAs and cellular proliferation
FIGURE 2 | Continued
transfections with SD indicated, A3). Levels of significance were computed
as described in Materials and Methods using the Mann-Witney test. Means
significantly different from the scrambled control mean are indicated by (∗).
(B) Panel presents typical results for cellular proliferation of E10 cells which
72 h earlier had been transfected with scrambled control, miR-20b - and
miR-363-5p mimic (B1), scrambled control, miR-92a mimic and miR-363-3p
mimic (B2). E10 cells incubated for 72 h in a serum free medium (starved
cells) were used as positive control. Cellular proliferation was assayed using
the Click-iT EdU Alexa Fluor® 488 kit. The numbers in parenthesis represent
the area under the high intensity fluorescence peak expressed as % of that
under corresponding peak for scrambled control. Serum starved E10 cells are
included as positive control showing complete inhibition of DNA replication.
Further experimental details are otherwise given in Materials and Methods.
FIGURE 3 | MicroRNAs differentially expressed in cultured human
squamous carcinoma (E10) cells transfected with scrambled control,
miR-19a -, miR-20b -, miR-92a, or miR-363-5p- mimic. The microRNA
transcriptome of E10 cells transfected with miR-19a -, miR-20b -, miR92a -, or
miR-363-5p mimic were individually compared against transcriptome from
scrambled control transfectants. ANOVA (P ≤ 0.05) was used for the isolation
of the 53 miRNA differentially expressed in transfectants with miR-19a mimic
(A), 43 miRNAs in miR-20b transfectants (B), 61 miRNAs in miR-92a
transfectants (C) and 29 miRNAs in transfectants with miR-363-5p mimic (D).
Each cluster was separately subjected to hierarchical clustering yielding the
heat diagrams shown in the figure. The heat-map was computed using
Spotfire DecisionSite for Microarray analysis as described in Materials and
Methods. The color scale indicates fluorescence intensities. The results were
obtained by microarray analysis of miRNA transcriptomes using four separate
transfections for each miRNA mimic and four scrambled control transfections
as described in Materials and Methods.
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background subtracted) normalized by scaling from 0 to 1. False
discovery rates (FDR) computed according to Hochberg and
Benjamini (1990) were used to correct selection of genes for false
positives (P < 0.05). Normalization between arrays was carried
out using Z-score normalization. Statistical analysis of microar-
ray data was carried out on data derived from triplicate slides
derived from three separate transfections. Results from batches of
slides were combined into a single data-file for statistical analysis
and subjected to ANOVA using SPOTFIRE software to isolate
differentially expressed miRNAs (p ≤ 0.05).
REVERSE TRANSCRIPTION OF miRNAs
TaqMan® MicroRNA Assay (hsa_miR-106a, hsa_miR-106b, hsa_
miR_17∗, hsa_miR_17, hsa_miR_18a, hsa_miR-18b, hsa_miR_
19a, hsa_miR-19b, hsa_miR_20a, hsa_miR-20b, hsa_miR-25,
hsa_miR_92a, hsa_miR-93, hsa_miR-363, miR-363-5p, and miR-
485-5p) and TaqMan® Control Assay (RNU48) were used to
reversely transcribe 40 ng of RNA, enriched with respect to
miRNA, to cDNA (AppliedBiosystems, Carlsbad, CA, USA).
Each 15µl reverse transcription reaction was performed accord-
ing to the manufacturer’s protocol and run in an Eppendorf
MasterCycler (Eppendorf GmbH, Hamburg, Germany).
QUANTITATIVE PCR (qRT-PCR)
TaqMan® MicroRNA qRT-PCR assay was used to validate
microarray results and to further investigate effects of transfection
with miRNAs-mimics on levels of paralogous miRNAs. Using
the TaqMan® Universal PCR Master Mix (AppliedBiosystems,
Carlsbad, CA, USA) the following assays were carried out: hsa_
miR-106a, hsa_miR-106b, hsa_miR_17∗, hsa_miR_17, hsa_
miR_18a, hsa_miR-18b, hsa_miR_19a, hsa_miR-19b, hsa_miR_
20a, hsa_miR-20b, hsa_miR-25, hsa_miR_92a, hsa_miR-93,
hsa_miR-363, miR-363-5p, and miR-485-5p, TaqMan® Control
Assay RNU48, TaqMan® Pri-miRNA Assay (hsa-pri-miR-106a,
hsa-pri-miR-106b, hsa-pri-miR-17, hsa-pri-miR-25, hsa-
pri-miR-92a-1, and hsa-pri-miR-92a-2) and TaqMan® Gene
Table 1 | Relative changes in levels of five selected mRNAs following
transfection of E10 cells with miR-20b - or miR-365-3p mimic.
Gene Fold change in level of mRNA
(transfected/scrambled control)
Transfected with Transfected with
miR-20b mimic miR-363-5p mimic
ATF1 0.8± 0.1 0.5± 0.1
EGFR 0.9± 0.1 0.9± 0.03
KRT14 1.0± 0.1 0.2± 0.02
KRT15 1.1± 0.1 0.3± 0.02
PSMB6 0.5± 0.02 0.1± 0.01
Levels of mRNAs encoded by AFT1, EGFR, KRT14, KRT15, or PSMB6 were
assayed using qRT-PCR with total RNA isolated from E10 cells transfected with
scrambled control or miR-20b - or miR-363-5p mimic. The tabulated mean val-
ues (with SD indicated) were derived from at least three biological replicates.
These five mRNAs were predicted to be targeted by miR-20b or miR-363-5p
using MicroCosm, IPA or SVMicro software. Experimental details are otherwise
given in Materials and Methods Section.
Expression Assays for TBP. Levels of expression miRNA were nor-
malized to that of a small nucleolar RNA, C/D box 48 (RNU48).
An internal control was also used to normalize between different
plates. The qRT-PCR reaction was performed according to the
manufacturer’s protocol using the Stratagene MX 3005 qRT-PCR
instrument (Agilent Technologies, Santa Clara, CA, USA). All
results were analyzed using multiple experiment analysis applying
a common threshold. All RNA samples were analyzed using both
technical and biological triplicates.
STATISTICAL ANALYSIS OF qRT-PCR DATA
The GenEx program (MultiD Analysis AB, Gothenburg, Sweden)
was used to calculate fold-changes in levels of expression and
to evaluate the significance of difference between Ct values.
Levels of expression were normalized using the gene encod-
ing the TATA-binding protein (TBP) as house-keeping. The
non-parametric Mann–Whitney test was used to test differences
between groups. Two-sided P ≤ 0.05 were considered statistically
significant. Results are presented as means with SD indicated.
BIOINFORMATIC ASSOCIATION OF DIFFERENTIALLY EXPRESSED
microRNAs WITH CELLULAR FUNCTIONS
Bioinformatic analysis of miRNAs found to be differentially
expressed was carried out using Ingenuity Pathways Analysis soft-
ware (IPA) (Ingenuity Systems Inc., Redwood City, CA, USA,
http://www.ingenuity.com). The principles of the algorithms
involved were reviewed by Kramer et al. (2014).
RESULTS
EFFECTS OF TRANSFECTION WITH miR-18a, miR-19a-, miR-20b-,
miR-92a-, miR-363-3p OR miR-363-5p MIMIC ON PROLIFERATION OF
CULTURED CARCINOMA CELLS
Cultured human squamous oral carcinoma cells (E10) exhib-
ited both altered morphology and diminished proliferation at
72 h after transfection with mimic for either miR-20b, or miR-
363-3p, or miR-363-5p. These cells appeared less elongated than
those of the other cultures investigated (Figure 2A1). In cultures
transfected with mimics for miR-20b or miR-363-5p the num-
ber of cells were about 55 and 75%, respectively, of that found in
scrambled control (Figure 2A3). Neither significantly decreased
number of cells, nor altered cell morphology, were found with
cells transfected with miR-18a - or miR-92a mimic (Figure 2A3).
In cultures transfected with miR-363-3p mimic less apparent
changes in cellular morphology were observed (Figure 2A1), even
though the number of cells were about 70% of that of the
scrambled control (Figure 2A3).
Assay of apoptosis revealed that no detectable stimulation
of apoptosis had occurred following transfection with miR-
363-5p mimic (Figure 2A2). Similar results were found with
other miRNA-mimic causing decreased cell density (results not
shown). Results presented in Figure 2 suggest that the signif-
icantly decreased cell densities observed with transfectants for
mimic of miR-19a, miR-20b -, miR-106a, miR-363-3p -, and
miR-363-5p were caused by diminished proliferation. Assay
of proliferation using the Click-iT EdU Alexa Fluor® 488
assay showed a markedly decreased fraction of these cells
exhibiting high intensity fluorescence (Figures 2B1,B2). The frac-
tion of cells exhibiting high intensity fluorescence ranged from
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57–81% of that found in the corresponding scrambled con-
trol peak. Serum starved cells were used a positive control
demonstrating virtual absence of DNA replication in such cul-
tures (Figures 2B1,B2). This demonstrates that DNA replication
is decreased in these cells (Diermeier-Daucher et al., 2009).
The lower value (57%) was found with cells transfected with
miR-20b mimic, also exhibiting the larger decline in cell density
(Figure 2A3). The 4% decrease in the high intensity fluorescence
peak observed with transfectants for miR-92a mimic was pre-
sumably too small to cause a detectable change in cell density
(Figure 2A3).
A markedly decreased number of cells was also observed with
cultured keratinocytes and HaCaT cells transfected with miR-
363-5p mimic (76 ± 2% and 74 ± 2% (n = 4) of scrambled
control, respectively) suggesting that this phenomenon is not
restricted to cultured E10 cells.
Table 2 | Differentially expressed miRNAs and significantly associated cellular functions.
Category p-Value Molecules
Cellular growth and proliferation 3,70E-09 miR-17-3p (and other miRNAs w/seed CUGCAGU), miR-17-5p (and other miRNAs w/seed
AAAGUGC), miR-18a-5p (and other miRNAs w/seed AAGGUGC), miR-19b-3p (and other miRNAs
w/seed GUGCAAA)
8,15E-07 let-7a-5p (and other miRNAs w/seed GAGGUAG), miR-17-3p (and other miRNAs w/seed
CUGCAGU), miR-17-5p (and other miRNAs w/seed AAAGUGC),miR-18a-5p (and other miRNAs
w/seed AAGGUGC), miR-19b-3p (and other miRNAs w/seed GUGCAAA), miR-24-3p (and other
miRNAs w/seed GGCUCAG), miR-29b-3p (and other miRNAs w/seed AGCACCA)
3,82E-04 miR-221-3p (and other miRNAs w/seed GCUACAU), miR-23a-3p (and other miRNAs w/seed
UCACAUU)
2,46E-03 let-7a-5p (and other miRNAs w/seed GAGGUAG),miR-29b-3p (and other miRNAs w/seed
AGCACCA)
3,56E-03 let-7a-5p (and other miRNAs w/seed GAGGUAG),miR-17-5p (and other miRNAs w/seed
AAAGUGC), miR-221-3p (and other miRNAs w/seed GCUACAU), miR-23a-3p (and other miRNAs
w/seed UCACAUU)
4,86E-03 miR-17-5p (and other miRNAs w/seed AAAGUGC)
8,49E-03 miR-221-3p (and other miRNAs w/seed GCUACAU)
Cell death 1,01E-04 let-7a-5p (and other miRNAs w/seed GAGGUAG), miR-17-3p (and other miRNAs w/seed
CUGCAGU), miR-17-5p (and other miRNAs w/seed AAAGUGC), miR-181a-5p (and other miRNAs
w/seed ACAUUCA), miR-221-3p (and other miRNAs w/seed GCUACAU), miR-29b-3p (and other
miRNAs w/seed AGCACCA)
4,14E-04 miR-181a-5p (and other miRNAs w/seed ACAUUCA), miR-221-3p (and other miRNAs w/seed
GCUACAU)
2,43E-03 miR-17-5p (and other miRNAs w/seed AAAGUGC)
3,65E-03 miR-181a-5p (and other miRNAs w/seed ACAUUCA)
4,86E-03 miR-221-3p (and other miRNAs w/seed GCUACAU)
5,86E-03 let-7a-5p (and other miRNAs w/seed GAGGUAG), miR-29b-3p (and other miRNAs w/seed
AGCACCA)
9,81E-03 miR-17-3p (and other miRNAs w/seed CUGCAGU), miR-181a-5p (and other miRNAs w/seed
ACAUUCA)
Cellular compromise 1,22E-03 miR-17-5p (and other miRNAs w/seed AAAGUGC)
Cell cycle 2,43E-03 miR-17-5p (and other miRNAs w/seed AAAGUGC)
Cell morphology 2,43E-03 miR-17-5p (and other miRNAs w/seed AAAGUGC)
Cellular movement 2,43E-03 miR-17-5p (and other miRNAs w/seed AAAGUGC)
9,70E-03 miR-221-3p (and other miRNAs w/seed GCUACAU)
3,36E-02 let-7a-5p (and other miRNAs w/seed GAGGUAG)
Cellular response to therapeutics 4,86E-03 miR-17-5p (and other miRNAs w/seed AAAGUGC)
Cell-to-cell signaling and interaction 6,07E-03 miR-29b-3p (and other miRNAs w/seed AGCACCA)
Ingenuity Pathways Analysis was used to detect cellular functions significantly associated with miRNAs found differentially expressed following transfection with
miR-19a - miR-20b -, miR-92a - or mir-363-5p mimic as shown in Figure 5. The Table presents the miRNAs found associated with the various cellular functions and
their associated Fisher’s Exact Test p-value. Experimental details are otherwise described in Materials and Methods.
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PROFILING OF miRNAs WHICH WERE DIFFERENTIALLY EXPRESSED IN
E10 CELLS TRANSFECTED WITH miR-19a-, miR-20b -, miR-92a -, OR
miR-363-5p MIMIC
Microarrays were used to profile miRNAs in cultured human
oral squamous carcinoma cells (E10) 72 h after transfection with
mimics for miR-19a -, miR-20b -, miR-92a -, or miR-363-5p
mimic or with scrambled control. Studies with miR-363-3p were
not included as miR-363-3p has been shown to have an anti-
proliferative effect (Sun et al., 2013).
The heat-map presented in Figure 3 resulted from hierarchical
clustering of 53, 43, 61 and 29 miRNAs found differentially
expressed (p ≤ 0.05) in E10 cells transfected with mimic for
miR-19a (A), miR-20b (B), miR-92a (C), or miR-363-5p - (D),
respectively. With miR-19a mimic transfectants (A) 46 of the 53
FIGURE 4 | Levels of selected proteins in cultured human squamous
carcinoma cells (E10) transfected with miR-20b - or miR-363-5p mimic.
Effects of transfection of E10 cells with miR-20b - or miR-363-5p mimic on
cellular levels of the proteins shown in the figure were investigated using
Western blotting. Typical Western blot images are shown; the histograms
showing integrated fluorescence intensities of the band of protein with
molecular weight corresponding to that of the protein being investigated. The
level of KRT15 protein in E10 cells is low, hence uncertain values for
quantitation of this protein. Experimental details are otherwise presented in
Materials and Methods.
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miRNAs exhibited significantly decreased expression, miR-19a,
miR-19b, and miR-20b being among the seven miRNA with
significantly increased expression. Similarly, with transfectants
for miR-363-5p mimic 27 of 29 miRNAs exhibited significantly
decreased expression (about 50% of the level found in scrambled
controls), only miR-363-5p and miR-485-5p exhibited increased
(some 40-fold) expression (D). In contrast, with miR-20b mimic
31 of 43 differentially expressed miRNAs exhibited decreased
expression (B). As expected, high levels of expression of miR-
19a/miR-19b, or miR-20b, or miR-363-5p were found in cells
transfected with mimic for miR-19a, or miR-20b - or miR-363-
5p, respectively. Only in cells transfected with miR-19a mimic
a high level of miR-20a was detected (A). One single miRNA,
miR-423-5p, was found differentially expressed (decreased by
about 50%) in transfectants for either miR-19a -, miR-20b -, or
miR-363-5p mimic.
In cells transfected with miR-92a-mimic a distinctly sepa-
rate population of miRNAs were found differentially expressed,
not containing any miRNA encoded by any one of the three
paralogous clusters (C).
CHANGES IN LEVELS OF EXPRESSION OF FIVE SELECTED GENES AND
IN LEVELS OF THE CORRESPONDING PROTEINS
Results obtained using qRT-PCR showed that ATF1, KRT14,
KRT15, and PSMB6 were differentially expressed in miR-363-
5p transfectants and AFT1 and PSMB6 in miR-20b transfec-
tants (Table 1). Although EGFR was not differentially expressed
(Table 1), it was found to be targeted by miR-20b and was
therefore also used for Western blotting.
The QRT-PCR results suggest that changes in levels of mRNAs
(Table 1) are mostely in agreement with results from Western
blotting (Figure 4). In cells transfected with miR-363-5p mimic,
however, and increased level of EGFR protein was observed
(Figure 4), suggesting that the level of EGFR protein is also
regulated at the level of translation.
SIGNIFICANT ASSOCIATIONS BETWEEN DIFFERENTIALLY EXPRESSED
microRNAs AND CELLULAR FUNCTIONS
Ingenuity Pathways Analysis was used to establish associations
between clusters of miRNAs and cellular functions. For cells
transfected with mimic for miR-19a, miR-20b, or miR-363-5p
(Figure 3) differentially expressed miRNAs yielded highly signifi-
cant associations to, e.g., “Cell Cycle,” “Cell Death,” and “Cellular
Growth and Proliferation” (Figure 5). In contrast, with miR-
NAs found differentially expressed following transfection with
miR-92a mimic (Figure 3) these associations were not found
(Figure 5). The miRNAs, and seed sequences, associated with the
various cellular functions are presented in Table 2.
EFFECTS OF TRANSFECTION OF CULTURED SQUAMOUS CARCINOMA
CELLS WITH miR-19a -, miR-20b -, miR-92a -, OR miR-363-5p MIMIC ON
LEVELS OF miRNAs ENCODED BY THE miR-17-92 CLUSTER
Microarray results suggested that levels of expression of five
members of the miR-17-92 cluster (miR-17, miR-18a, miR-19a,
miR-19b, and miR-92a) were significantly decreased only in cells
transfected with miR-363-5p mimic (Figure 3). These findings
were confirmed using qRT- PCR (Figure 6). The levels of expres-
sion of the mature miRNAs from this cluster were 50-70%
of that observed in cells transfected with scrambled control
(Figure 6).
Results presented in Figure 6 also show levels of expression of
the various miRNAs of the miR-17-92 cluster after transfection
with mimics for miR-19a, miR-20b or miR-92a. Although sig-
nificantly decreased levels of expression of two or three mature
miRNAs were observed, no systematic pattern is apparent. Results
for miR-17 and miR-20a are uncertain as the assay is unlikely
to selectively measure miR-17 and miR-20a due to their close
homology to miR-20b (Figure 1), a problem compounded by the
high level of miR-20b mimic in these transfected cells. Similarly,
FIGURE 5 | Bioinformatic analysis of miRNAs found differentially
expressed in cultured human squamous carcinoma cells (E10)
transfected with miR-19a -, miR-20b -, miR-92a -, or miR-363-5p mimic.
The miRNAs (53, 43, 61 and 29) found differentially expressed following
transfection with miR-19a - miR-20b -, miR-92a -, or mir-363-5p mimic were
subjected to bioinformatic analysis using Ingenuity Pathways Analysis. The
cellular functions significantly (p ≤ 0.05) associated with these miRNA are
illustrated using histograms. The horizontal lines indicate the threshold at a
level of significance when p = 0.05. The level of significance was
computed as the Fisher’s Exact Test p-value. Experimental details are
otherwise described in Materials and Methods.
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FIGURE 6 | Levels of expression of the microRNAs encoded by the
miR-17-92 cluster in cultured human squamous carcinoma cells (E10)
following transfection with miR-19a -, miR-20b -, miR-92a -, or
miR-363-5p mimic. Fractions of RNA enriched with respect to microRNA
were isolated from cultured human squamous carcinoma cells (E10)
transfected with mimic for miR-363-5p (A), miR-92a - (B), miR-20b - (C),
miR-19a - (D) mimic or scrambled control as shown in the Figure. Levels
of expression of the various microRNAs encoded by the miR-17-92
cluster (shown in Figure) were assayed by qRT-PCR. Fold changes in
expression and statistical parameters were calculated using the GenEx
program. The plotted data represents mean values ±SD derived from at
least three transfections. Median levels of expression significantly
different from that of scrambled control are indicated by (∗). Experimental
details are otherwise given in Materials and Methods.
in cells transfected with miR-19a mimic selective assay of miR-
19b is unlikely because these miRNAs differ by a single nucleotide
only (Figure 1).
EFFECTS OF TRANSFECTION OF CULTURED SQUAMOUS CARCINOMA
CELLS WITH miR-19a -, miR-20b -, miR-92a -, OR miR-363-5p MIMIC ON
LEVELS OF miRNAs ENCODED BY THE miR-106a-363 OR miR-106b-25
CLUSTERS
Results from microarrays (Figure 3) and qRT-PCR (Figure 7)
suggested that levels of expression of all members of the
miR-106b-25 cluster (miR-106b, miR-25, and miR-93) were
decreased in cells transfected with miR-20b mimic or with miR-
363-5p mimic (Figures 7A,B).
In cells transfected with miR-19a - or miR-92a mimic no
systematic changes in expression of miRNAs was apparent
(Figures 7B,D).
Results presented in Figure 8 show relative levels of expres-
sion of the miRNAs encoded by the miR-106a-363 cluster after
transfection of E10 cells with mimic for miR-19a-, miR-20b -,
miR-92a -, or miR-363-5p. Only miR-19b, miR-20b, miR-92a,
and miR-106a were detectable in these cells. A general decrease
in all detected miRNA was found only in cells transfected
with miRNA-363-5p mimic (Figure 8A). Transfection with miR-
20b mimic led to 60% increase in the level of miRNA-106a
(Figure 8C), while in cells transfected miR-19a mimic the level
of miR-20b was increased 4-fold (Figure 8D) in agreement
with microarray results (Figure 3). In all other transfected cells,
including scrambled control, miR-20b was barely detectable. It
is, however, possible that measured miR-19b and miR-92a were
derived from the miR-17-92 transcript. Therefore, miR-20b and
miR-106a may be the only mature microRNAs exclusively origi-
nating from the miR-106a-363 transcript.
Although the sequence of miR-20b differs from that of miR-
106a by 3 bases (Figure 1) the specificity of assay of assay of
miR-106a in cells transfected with miR-20b mimic is some-
what uncertain (Figure 8C). This point is more appropriate as
regards assays of miR-19b in cells transfected withmiR-19amimic
(Figure 8D), these two miRNAs differing by 2 bases (Figure 1).
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FIGURE 7 | Levels of expression of the microRNAs encoded by the
miR-106b-25 cluster in cultured human squamous carcinoma cells (E10)
following transfection with miR-19a miR-20b -, miR-92a -, or miR-363-5p
mimic. Fractions of RNA enriched with respect to microRNA were isolated
from cultured human squamous carcinoma cells (E10) transfected with
miR-363-5p (A), miR-92a - (B), miR-20b - (C), miR-19a - (D) mimic or
scrambled control shown in the Figure. Levels of the various microRNAs
encoded by the miR-106b-25 cluster (shown in the Figure) were assayed by
qRT-PCR. Statistical calculations were carried out using the GenEx program.
Median levels of expression significantly different from that of scrambled
control are indicated by (∗). Experimental details are otherwise given in
Materials and Methods.
EFFECTS OF TRANSFECTION CULTURED HUMAN SQUAMOUS
CARCINOMA CELLS WITH miR-19a -, miR-20b -, miR-92a -, OR
miR-363-5p MIMIC ON EXPRESSION OF THE PRIMARY TRANSCRIPTS
pri-17-92, pri-106a-363, AND pri-106b-25
The levels of expression of hsa-pri-miR-17, hsa-pri-miR-92a-1,
hsa-pri-miR-106b, hsa-pri-miR-25, hsa-pri-miR-106a, and hsa-
pri-miR-92a-2 were measured in E10 cells after transfection with
miR-19a, miR-20b -, miR-92a -, or miR-363-5p mimic. The
results for pri-miR-17-92 and pri-miR-106b-25 are presented in
Figure 9.
Results in Figure 9A show the level of expression of hsa-pri-
miR-92a-1 was higher than that of hsa-pri-miR-17 in all cells
investigated. In cells transfected with miR-363-5p mimic levels
of expression of both pri-miR-17 and pri-miR-92a-1 were sig-
nificantly decreased. This correlates with the observed decrease
in levels of mature miRNAs encoded by the cluster following
transfection with miR-363-5p mimic (Figure 6A).
Transfection with miR-92a mimic had no significant effect
on levels of expression of either of the pri-transcripts (Figure 9).
Transfection with miR-20b mimic, however, significantly
increased expression of pri-miR-17, while that of the pri-
miR-92a-1 transcript was unaffected (Figure 9). Transfection
with miR-19a mimic resulted in significantly increased expres-
sion of both pri-miR-17 - and pri-miR-92a-1 transcript
(Figure 9).
Results presented in Figure 9 show that the level of expression
of the pri-miR-25 transcript was higher than that of the pri-miR-
106b transcript. In cells transfected with miR-363-5p mimic the
level of expression of both of these transcripts were decreased.
This correlates with the observed decreased expression of the
mature miRNAs encoded by this cluster following transfection
with miR-363-5p mimic (Figure 7A). In cells transfected with
miR-19a -, miR-20b -, or miR-92a mimic, the primary transcripts
exhibited significantly increased levels of expression (Figure 9).
The relative levels of primary transcripts from the three clus-
ters were rather different, also in a 5′-/3′-specific manner. Using
the level of expression of the pri-miR-17 (5′-end) transcript as
reference, that of pri-miR-92a-1(3′-end) was 4.6± 0.7 fold higher
and those of pri-miR-106b (5′-end) and pri-miR-25 (3′-end) were
8.4 ± 2.0 - and 52.1 ± 4.1-fold higher, respectively. Similarly,
the level of expression of pri-miR-106a (3′-end) was 0.0003 ±
0.00006, while that of pri-miR-92a-2 (3′-end) was not detectable
in any of the samples assayed (also in HTC116 and HT29 cells,
results not shown). This likely explains why only miR-106a is
detected in E10 cells.
DISCUSSION
An anti-proliferative effect has previously been observed for
miR-19a (Qin et al., 2010), miR-106a (Yang et al., 2011) and
miR-363-3p (Sun et al., 2013). Searching the literature revealed
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FIGURE 8 | Levels of expression of the microRNAs encoded by the
miR-106a-363 cluster in cultured, human squamous carcinoma cells
(E10) following transfection with miR-19a, miR-20b -, miR-92a -, or
miR-363-5p mimic. Fractions of RNA enriched with respect to microRNA
were isolated from cultured human squamous carcinoma cells (E10)
transfected with miR-363-5p (A), miR-92a - (B), miR-20b - (C), miR-19a - (D)
or scrambled control. Levels of the various microRNAs encoded by the
miR-106a-363 cluster (shown in Figure) were assayed by qRT-PCR. Statistical
calculations were carried out using the GenEx program. Median levels of
expression significantly different from that of scrambled control are indicated
by (∗). Experimental details are otherwise given in legend in Materials and
Methods.
no such findings as regards miR-20b and miR-363-5p. Because
overexpression of miR-17-92 - or miR-106a-363 cluster is asso-
ciated with stimulated proliferation/cancer (Landais et al., 2007;
Lu et al., 2007) the observed anti-proliferative effect found with
miR-20b and 363-5p transfectants was unexpected. It may, how-
ever, be associated with the relatively low levels of miR-20b and
miR-363-5p found in E10 cells (Figure 8).
The pleiotropic functions of the miR-17-92 cluster and its par-
alogs are perhaps their more striking feature (reviewed by Olive
et al., 2010). Although high levels of expression are associated
with cancer, information on specific effects of individual miRNA
is invariably incomplete. The present findings provide new data
as regards possible functions of individual miRNAs, while also
suggesting that themechanism regulating their expression is com-
posite in nature. This is exemplified by the selective 50-fold
increase in the level of the anti-proliferative miR-20b in transfec-
tants for miR-19a-mimic (Figure 8D), which also exhibited about
25% decrease in cell density (Figure 2A3). Likewise, the more
potent anti-proliferative miR-20b decreased expression miR-19a
and miR-93 (Figures 6C, 7C) as well as increasing the level of
miR-106a by about 60% (Figure 8C); changes consistent with
an anti-proliferative effect (Qin et al., 2010; Fang et al., 2011).
Results obtained with transfectants for miR-363-5p further illus-
trate the heterogeneity of effects on sibling miRNAs: only in these
transfectants were levels of the sibling miRNAs from all three
clusters found significantly decreased (Figures 6–9). Indeed, it
is conceivable decreased proliferation here is associated with a
generalized decreased expression of cluster miRNAs—in line with
the association of high levels of expression of miR-17-92 cluster
in proliferating tissues. The decreased levels of miRNAs can be
associated with diminished transcription of the cluster genes as
suggested by a general decrease in levels of both mature miRNAs
and of corresponding primary transcript in transfectants for miR-
363-5p mimic (Figures 6–9). The reason for the increased level of
primary transcript found with other transfectants is not apparent.
In this study most the observed changes in levels of most
miRNAs ranged from −2- fold to +5-fold, with a few excep-
tions. Changes in expression of miRNAs on this scale have been
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FIGURE 9 | Levels of the miR-17-92 - and the miR-106b-25 primary
transcript in cultured human squamous carcinoma cells (E10)
following transfection with mimic for miR-19a, miR-20b, miR-92a, or
miR-363-5p. Total RNA were isolated from cultured human squamous
carcinoma cells (E10) transfected with miR-19a, miR-20b -, miR-92a -
miR-363-5p mimic or scrambled control. The hsa-pri-mir-17,
hsa-pri-miR-92a-1, hsa-pri-miR-106b and hsa-pri-miR-25 were assayed by
qRT-PCR. The plotted mean fold changes in level of expression (with SD
indicated) were derived from at least three separate transfections.
Statistical calculations were carried out using the GenEx program. Mean
values denoted by identical letters are not significantly different; those
denoted by different letters are significantly different (P < 0.05).
Experimental details are otherwise given in Materials and Methods.
considered to be biologically significant (Hidaka et al., 2012;
Van Iterson et al., 2013; Yamada et al., 2013). Western blotting
results, with proteins selected from among miRNA targets, can
be regarded to verify this as all exhibited altered levels in cells
transfected with mimic for miR-20b or miR-363-5p (Figure 4).
Among miRNAs encoded by the miR-106a-363 cluster only
miR-106a is expressed at detectable levels in E10 cells. All tested,
non-expressed; miRNAs caused 30–50% inhibition of prolifera-
tion. It is therefore possible also non-expressed members of this
clusters may exert an anti-proliferative effect in some populations
of cells, hence their non-expression in carcinoma (E-10) cells.
Whether the distinct populations of differentially expressed
miRNAs found in transfectants for miR-19a -, miR-20b -, or miR-
363-5p mimic (Figure 3) reflect different ant-proliferative mech-
anisms remains to be established. It is, however, noteworthy, that
miR-92a-transfectants (exhibiting no change in proliferation)
yielded an entirely different population of miRNAs (these trans-
fectants also rarely exhibiting significant changes in expression of
any cluster miRNAs, Figures 6–9).
Only miR-423-5p was shared between the 30–50 differentially
expressed miRNAs in cells transfected with mimic for miR-19a,
miR-20b, or miR-363-5p. However, high levels of expression
of miR-423-5p has been found in breast—(Van Der Auwera
et al., 2010) and hepatocellular tumors (Murakami et al., 2013).
Therefore, the decreased expression (about 50%) of miR-423-5p
observed in these transfected cells is therefore in line with pub-
lished findings and may have contributed to inhibition of prolif-
eration. A similar case can be made as regards the 40-fold increase
in the level of miR-485-5p in cells transfected with miR-363-5p
mimic, as miR-485-5p has been shown to functions as a tumor
suppressor in breast carcinoma cells (Anaya-Ruiz et al., 2013).
In spite of the diverse composition of the clusters of dif-
ferentially expressed miRNAs in cells exhibiting inhibition of
proliferation (Figure 3), the three clusters nevertheless yielded
similar significantly associated cellar functions, e.g., “Cell Cycle,”
“Cell Death,” and “Cell-to-Cell Signaling and Interaction.” This
may be taken to indicate that different anti-proliferative mech-
anisms operate in the various transfectants, as also suggested
by results from Western blotting analysis. The cluster derived
from miR-92-transfectants, however, yielded no such signifi-
cantly associations (Figure 5) lend support to the suggestion that
the anti-proliferative mechanism entails altered expression of
miRNAs. The precise molecular mechanisms involved, however,
remains to be established.
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Supplementary Figure 1 | The Figure show micrographs of E10 cells
transfected with scrambled control, miR-20b -, miR-363-3p or miR-363-5p
mimic. Both miR-20b and miR-363-5p transfectants showed altered
morphology; cells appeared larger and less elongate than scrambled
control cells. With miR-363-3p transfectants changes in morphology were
less clear, the cells appearing more like those of the scrambled control.
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